SCHEMBL30611894

SCHEMBL30611894

CCn1ccc2c(C(=O)OC)cc(Cl)nc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.52
▸ NR4A2 P43354 1/20 0.43
▸ BRD4 O60885 1/20 0.42
▸ ALDH1A1 P00352 8/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ HPGD P15428 2/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ ALOX12 P18054 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ TSHR P16473 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ GLA P06280 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ CASP7 P55210 1/20 0.39
▸ CD38 P28907 1/20 0.38
▸ MAPT P10636 3/20 0.38
▸ POLB P06746 1/20 0.38
▸ PLA2G2A P14555 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26107710 1.00 KDM4E (0.52) KDM4ENR4A2BRD4ALDH1A1SMN1; SMN2
SCHEMBL31347186 0.86 KDM4E (0.49) KDM4EALDH1A1SMN1; SMN2HPGDNPC1
SCHEMBL26105230 0.86 KDM4E (0.49) KDM4EALDH1A1SMN1; SMN2HPGDNPC1
SCHEMBL31347137 0.85 KDM4E (0.48) KDM4EALDH1A1SMN1; SMN2HPGDNPC1
SCHEMBL30612114 0.85 KDM4E (0.48) KDM4EALDH1A1SMN1; SMN2HPGDNPC1
SCHEMBL30611844 0.85 KDM4E (0.48) KDM4EALDH1A1SMN1; SMN2HPGDTSHR
SCHEMBL26107749 0.85 KDM4E (0.57) KDM4EALDH1A1NPC1GAAMAPT
SCHEMBL31347211 0.85 KDM4E (0.57) KDM4EALDH1A1NPC1GAAMAPT
SCHEMBL26105877 0.85 KDM4E (0.48) KDM4EALDH1A1SMN1; SMN2HPGDTSHR
SCHEMBL26107397 0.85 KDM4E (0.48) KDM4EALDH1A1SMN1; SMN2HPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119585252-A Bicyclic heteroaryl containing compounds as IKZF2 degrading agents 翁科皮亚治疗公司和SK生命科学实验室 2025-03-07 — — CN disclosed
EP-4499629-A1 BICYCLIC HETEROARYL-CONTAINING COMPOUNDS AS IKZF2 DEGRADERS Oncopia Therapeutics, Inc. D/B/A SK Life Science Labs (US) 2025-02-05 — — EP disclosed
WO-2023183919-A1 BICYCLIC HETEROARYL-CONTAINING COMPOUNDS AS IKZF2 DEGRADERS ONCOPIA THERAPEUTICS, INC. D/B/A PROTEOVANT THERAPEUTICS, INC. (US) 2023-09-28 — — WO disclosed
Send feedback